Inhibition of the Cyclin-Dependent Kinases (CDK) 4/6 as Therapy for Estrogen Receptor Positive Breast Cancer

Aurelio B Castrellon, Steven M Nguyen, Luis E Raez

Open source

DOI
10.21767/2254-6081.1000123
Published
2017
Container
Archives in Cancer Research
Publisher
Scitechnol Biosoft Pvt. Ltd.
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.21767/2254-6081.1000123,
  title = {Inhibition of the Cyclin-Dependent Kinases (CDK) 4/6 as Therapy for Estrogen Receptor Positive Breast Cancer},
  author = {Aurelio B Castrellon and Steven M Nguyen and Luis E Raez},
  year = {2017},
  journal = {Archives in Cancer Research},
  doi = {10.21767/2254-6081.1000123},
  url = {https://doi.org/10.21767/2254-6081.1000123}
}

RIS

TY  - JOUR
TI  - Inhibition of the Cyclin-Dependent Kinases (CDK) 4/6 as Therapy for Estrogen Receptor Positive Breast Cancer
AU  - Aurelio B Castrellon
AU  - Steven M Nguyen
AU  - Luis E Raez
PY  - 2017
JO  - Archives in Cancer Research
DO  - 10.21767/2254-6081.1000123
UR  - https://doi.org/10.21767/2254-6081.1000123
ER  - 

APA

Castrellon, A. B., Nguyen, S. M., & Raez, L. E. (2017). Inhibition of the Cyclin-Dependent Kinases (CDK) 4/6 as Therapy for Estrogen Receptor Positive Breast Cancer. Archives in Cancer Research. https://doi.org/10.21767/2254-6081.1000123

Source records